gainbot
BriefMoversScreensSectorsEarningsIPOsNewsDividends & splitsScreenerWatchlistLearn
NASDAQ · RXSTHealthcareOphthalmic Goods

RxSight, Inc. Common Stock (RXST)

$4.54−9.02%
Close Nov 5, 2026 · split-adjusted
Nov 5, 2026$4.50▼ 50.06% in range
Nov 4, 2025Low $4.50 · High $13.09Nov 5, 2026
What changed · written from our data
As of Nov 5, 2026

RxSight closed at $4.54 on Nov 5, down 9.02%, within 0.7% of its 52-week closing low. Volume of 1.5M shares was 1.90× its 20-day average (above normal).

Split-adjusted performance: -5.4% over one month, -21.7% over six months, -49.6% over one year.

In the quarter ended Sep 30, 2026, revenue was $24.59M, down 19.0% from a year earlier, with a net margin of -66.2%.

Short interest was 4.1M shares at the Oct 15 settlement (10.5% of float, 6.1 days to cover).

Market cap$190.4M41.9M shares
Revenue · quarter$24.6M−19.0% YoY
Diluted EPS$-0.39—
P/E · TTM—P/S 1.6×
Net margin-66.2%Gross 73.6%
Dividend yieldNone
52-week range4.51 – 13.09−65.3% from high
Volume1.5M1.90× 20-day avg
Volatility · 60d53.8%Annualised
Short % of float10.5%6.1 days to cover
Net cash$254.7MCash $254.7M
Next earnings—Not scheduled
Split-adjusted performance
1W −10.1%1M −5.4%3M −27.5%6M −21.7%YTD −56.4%1Y −49.6%3Y −79.5%5Y −62.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Ophthalmic Goods

Percentile among 7 companies (100 = best)

6-month momentum—
Revenue growth—
Net margin—
Value (low P/E)—
Size—

Industry medians: 6-month return −4.1%, revenue growth +2.5%, net margin 2.3%, P/E 222.2×.

Short interest

Details →
Shares short4.1M+0.8% vs prior
Days to cover6.1Settled Oct 15
% of float10.5%
Short vol. 10d38.5%of daily volume

Closest peers by size in Ophthalmic Goods

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
RXSTRxSight$4.54−9.02%−21.7%−19.0%−66.2%—$190.4M
STAAStaar Surgical Co$26.72−1.66%−2.1%−12.0%6.7%2,528.0$1.34BCompare
EYENational Vision Holdings$17.85−0.50%−21.8%+2.5%2.5%28.1$1.41BCompare
WRBYWarby Parker$26.08+22.50%−4.1%+9.8%2.0%416.4$3.22BCompare
LUCYInnovative Eyewear$0.8210−2.69%−21.8%+74.5%−165.3%—$7.2MCompare
BLCOBausch + Lomb$19.92−3.30%+25.2%+7.3%2.3%—$7.12BCompare
COOThe Cooper Companies$63.51−1.41%+3.9%+0.6%40.6%21.2$12.08BCompare

News about RxSight

All news →
RxSight, Inc. (RXST) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research · 2d ago▼ NegativeK2 Vision Has Been Recognized as the Highest-Volume Light Adjustable Lens practice in the worldGlobeNewswire Inc. · Oct 16, 2026▲ Positive

Quick answers

What does RxSight do?
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery.
What is RXST's market cap?
$190.36M, based on the Nov 5 close of $4.54.
Does RxSight pay a dividend?
No regular cash dividend has been paid in the last year.
How much of RXST is sold short?
4.1M shares, 10.5% of float, as of Oct 15, 2026.
What sector is RXST in?
Healthcare, in the Ophthalmic Goods industry.

About RxSight

RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.

HQ: Aliso Viejo, CA461 employeesListed Jul 30, 2021rxsight.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology